Cargando…
Nucleoside analogue 2’-C-methylcytidine inhibits hepatitis E virus replication but antagonizes ribavirin
Hepatitis E virus (HEV) infection has emerged as a global health issue, but no approved medication is available. The nucleoside analogue 2’-C-methylcytidine (2CMC), a viral polymerase inhibitor, has been shown to inhibit infection with a variety of viruses, including hepatitis C virus (HCV). Here, w...
Autores principales: | Qu, Changbo, Xu, Lei, Yin, Yuebang, Peppelenbosch, Maikel P., Pan, Qiuwei, Wang, Wenshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602043/ https://www.ncbi.nlm.nih.gov/pubmed/28623406 http://dx.doi.org/10.1007/s00705-017-3444-8 |
Ejemplares similares
-
6-Thioguanine inhibits rotavirus replication through suppression of Rac1 GDP/GTP cycling
por: Yin, Yuebang, et al.
Publicado: (2018) -
Inhibition of hepatitis E virus replication by proteasome inhibitor is nonspecific
por: Xu, Lei, et al.
Publicado: (2014) -
2’-Fluoro-2’-deoxycytidine inhibits murine norovirus replication and synergizes MPA, ribavirin and T705
por: Yu, Peifa, et al.
Publicado: (2020) -
Genotype-specific acquisition, evolution and adaptation of characteristic mutations in hepatitis E virus
por: Ikram, Aqsa, et al.
Publicado: (2017) -
Mitochondria in the biology, pathogenesis, and treatment of hepatitis virus infections
por: Qu, Changbo, et al.
Publicado: (2019)